Arrowhead Pharmaceuticals
Pasadena, CA
Arrowhead Pharmaceuticals, Inc. operates as a biotechnology company. The Company develops medicines that treat intractable diseases by silencing the genes. Arrowhead Pharmaceuticals offers its services in the United States.
arrowheadpharma.comCompany Details
Founded
- 1989
Employees
- 609 employees
Raised
- $1,624,882,944
Headquarters Location
- Pasadena, CA
Public
- Yes
Acquired
- No
CEO
Christopher Anzalone
Founders
- Mark M. DavisRobert Stewart
Company Collections
These are collections Arrowhead Pharmaceuticals is a part of. Click on the collection name to view similar companies.
Arrowhead Pharmaceuticals' Industries
Arrowhead Pharmaceuticals' Tech Stack
Arrowhead Pharmaceuticals Headquarters Location
Total Amount Raised: $1,624,882,944
Arrowhead Pharmaceuticals Funding Rounds
Post Ipo Equity
$325,000,000
Post Ipo Equity Investors
Sarepta TherapeuticsPost Ipo Debt
$400,000,000
Post Ipo Debt Investors
Sixth StreetPost Ipo Equity
$450,000,000
Post Ipo Equity
$266,800,000
Post Ipo Equity
$9,600,000
Post Ipo Equity Investors
Silence TherapeuticsPost Ipo Equity
$45,000,000
Post Ipo Equity Investors
OrbiMed AdvisorsPost Ipo Equity
$60,000,000
Post Ipo Equity Investors
RA Capital ManagementPost Ipo Equity
$36,000,000
Post Ipo Equity
$3,222,896
Post Ipo Equity
$2,760,000
Post Ipo Equity
$16,500,000
Post Ipo Equity Investors
York Capital ManagementPost Ipo Equity
$10,000,000
IPO
Unknown
Arrowhead Pharmaceuticals Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Arrowhead Pharmaceuticals.